Subdermal re-injection:: a method to increase surgical detection of the sentinel node in breast cancer without increasing the false-negative rate

被引:16
作者
Bajén, MT
Benítez, A
Mora, J
Ricart, Y
Ferran, N
Guirao, S
Carrera, D
Gil, M
Pla, MJ
Gumá, A
Palacin, JA
Martin-Comin, J
机构
[1] Hosp U Bellvitge, Hosp Llobregat, S Med Nucl, Barcelona 08907, Spain
[2] Hosp Univ Bellvitge, IDIBELL, Dept Nucl Med, Breast Unit, Barcelona, Spain
[3] Inst Catala Oncol, IDIBELL, Dept Oncol, Breast Unit, Barcelona, Spain
[4] Hosp Univ Bellvitge, IDIBELL, Dept Gynecol, Breast Unit, Barcelona, Spain
[5] Hosp Univ Bellvitge, IDIBELL, Dept Radiol, Breast Unit, Barcelona, Spain
[6] Hosp Univ Bellvitge, IDIBELL, Dept Plast Surg, Breast Unit, Barcelona, Spain
关键词
D O I
10.1007/s00259-005-1931-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The aim of this study was to evaluate in breast cancer whether subdermal (SB) re-injection improves surgical detection (SD) of the sentinel node (SN) in patients with negative lymphoscintigraphy on peritumoral ( PT) injection, without increasing the false-negative (FN) rate. Methods: Group I comprised 261 patients with invasive breast cancer > 3 cm and clinically negative axilla treated with primary chemotherapy. Axillary lymphadenectomy was performed in all of these patients. Group IA comprised 201 patients with PT injection, while group IB comprised 60 patients with SB injection in the tumour quadrant. Group II comprised 652 patients with breast cancer < 3 cm; in 73 of these patients with negative lymphoscintigraphy, SB re-injection was performed. For lymphoscintigraphy, 37 - 55 MBq Tc-99m-albumin nanocolloid in 1 ml was used for PT injection, and 18 MBq in 0.2 ml for SB injection. Five-minute images were obtained 2 h p.i. for PT injection and 20 - 30 min p.i. for SB injection. SD was performed 4 or 24 h p.i. Lymphoscintigraphic (LD), surgical and internal mammary (IM) detection rates were calculated. In group I, FN, negative predictive value (NPV) and accuracy ( A) were calculated. Statistical analysis was performed using the chi-square test. Results: In percentages, results were as follows: Group IA: SD: 84.1, FN: 13.6, NPV: 88.9, A: 78.6, IM: 14.5*. Group IB: SD: 90, FN: 0, NPV: 100, A: 90, IM: 1.7* (* p< 0.025). Group II: PT injection only: LD: 82.4, SD: 94; PT injection+ SB re-injection: LD: 90, SD: 98.5. SD was 97.8** in patients with positive lymphoscintigraphy and 58.5** when lymphoscintigraphy was negative (** p< 0.001). Conclusion: For correct staging, including extra-axillary drainage, peritumoural injection should first be performed. When the SN is not visualised, and only in those cases, SB re-injection should be performed, which increases the SD rate without increasing the FN rate.
引用
收藏
页码:338 / 343
页数:6
相关论文
共 27 条
[1]   Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma-detecting probe [J].
Alazraki, NP ;
Styblo, T ;
Grant, SF ;
Cohen, C ;
Larsen, T ;
Aarsvold, JN .
SEMINARS IN NUCLEAR MEDICINE, 2000, 30 (01) :56-64
[2]   Different sites and modes of tracer injection for mapping the sentinel lymph node in patients with breast cancer [J].
Bianchi, P ;
Villa, G ;
Buffoni, F ;
Agnese, G ;
Gipponi, M ;
Costa, R ;
Maragliano, C ;
Canavese, G ;
Mariani, G .
TUMORI, 2000, 86 (04) :307-308
[3]   Intradermal isotope injection: A highly accurate method of lymphatic mapping in breast carcinoma [J].
Boolbol, SK ;
Fey, JV ;
Borgen, PI ;
Heerdt, AS ;
Montgomery, LL ;
Paglia, M ;
Petrek, JA ;
Cody, HS ;
Van Zee, KJ .
ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (01) :20-24
[4]   Functional lymphatic anatomy for sentinel node biopsy in breast cancer - Echoes from the past and the periareolar blue method [J].
Borgstein, PJ ;
Meijer, S ;
Pijpers, RJ ;
van Diest, PJ .
ANNALS OF SURGERY, 2000, 232 (01) :81-89
[5]   Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer [J].
Burak, WE ;
Hollenbeck, ST ;
Zervos, EE ;
Hock, KL ;
Kemp, LC ;
Young, DC .
AMERICAN JOURNAL OF SURGERY, 2002, 183 (01) :23-27
[6]   Comparison of subdermal and peritumoral injection techniques of lymphoscintigraphy to determine the sentinel lymph node in breast cancer [J].
Eroglu, A ;
Mudun, A ;
Berberoglu, K ;
Asoglu, O ;
Ozmen, V ;
Muslumanoglu, M ;
Bozfakioglu, Y ;
Yavuz, E ;
Tuzlali, S ;
Cantez, S .
CLINICAL NUCLEAR MEDICINE, 2004, 29 (05) :306-311
[7]  
Feezor RJ, 2002, AM SURGEON, V68, P684
[8]   Sentinel node localization in patients with non-palpable breast cancer [J].
Fernández, A ;
Escobedo, A ;
Benito, E ;
Azpeitia, D ;
Gumà, A ;
Prieto, L ;
Moreno, A ;
Martin-Comin, J .
NUCLEAR MEDICINE COMMUNICATIONS, 2002, 23 (12) :1165-1169
[9]   Subareolar versus peritumoral injection for location of the sentinel lymph node [J].
Klimberg, VS ;
Rubio, IT ;
Henry, R ;
Cowan, C ;
Colvert, M ;
Korourian, S .
ANNALS OF SURGERY, 1999, 229 (06) :860-864
[10]  
Krynyckyi B. R., 2003, NUCL MED ANN, P131